AustinPx, a contract development and manufacturing organization specializing in bioavailability enhancement for orally delivered small molecule drugs, announced the introduction of the KinetiLease™ program, allowing pharmaceutical companies to lease the company’s KinetiSol™ research-scale equipment. This program enables companies to integrate this powerful amorphous dispersion manufacturing tool into their own R&D labs. Additionally, the company has… Continue reading AustinPx Launches KinetiSol™ Equipment Lease Program